Crossmark

From bench to bedside: Emerging therapeutics for alzheimer's disease in clinical trials

Crossref DOI link: https://doi.org/10.1007/s11011-026-01793-0

Published Online: 2026-03-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Verma, Mansi https://orcid.org/0000-0003-1105-0823
Singh, Niraj Kumar https://orcid.org/0000-0002-5625-5067
License Information

Text and Data Mining valid from 2026-03-18

Version of Record valid from 2026-03-18
More Information

Article History

Received: 8 July 2025

Accepted: 15 January 2026

First Online: 18 March 2026

Declarations

:

: Not Applicable.

: The authors declare no competing interests.